FDA Plans To Ease Approval Process For Alzheimer’s Drugs
Here’s a breakthrough, though not in the lab, that could tremendously boost research on Alzheimer’s drugs: The Food and Drug Administration plans to ease up its requirements to approve such medications. It was actually more than a month ago, in early February, that the FDA announced its new draft guidance..
Read more
